American Journal of Epidemiology Vol. 147, No. 4: 387-390
Copyright © 1998 by The Johns Hopkins University School of Hygiene and Public Health
other |
Hormone Replacement Therapy and the Risk of Hospitalization for Venous Thromboembolism: A Population-based Study in Southern Europe
1Global Pharmacoepidemiology, Clinical Development and Regulatory Affairs, Novartis Pharmaceuticals Barcelona, Spain
2 CEIFE, Centro Espaniol de Investigación Farmacoepidemio-lÓgica Mardrid, Spain
3 Azienda Ospedatera S. M. Misericordia Udine, Italy
4 Direzione Regionale Sanità Trieste, Italy
5 Insiel, Udin, Italy
Reprint requests to Dr. Cristina Varas-Lorenzo, Globla Pharmacoepidemiology, Novartis Farmaceutica SA, Gran Via Corts Catalanes 764, Barcelona, 08013, Spain.
The authors evaluated the risk of venous thromboembolism associated with hormone replacement therapy in a cohort of 265, 431 women aged 45–79 years who did not have major risk factors for venous thrombo-embolism. Through review of hospital charts, 171 cases were confirmed (pulmonary embolism = 77; deep venous thrombosis = 94). Ten thousand controls were randomly sampled. The risk of venous thromboem-bolism among nonusers of hormone replacement therapy was 1.3 per 10, 000 women per year. Current users of hormone replacement therapy had 2.3 times higher risk of venous thromboembolism (95 percent confidence interval 1.0–5.3) compared with nonusers. The increased risk was restricted to the first year of treatment. Am J Epidemiol 1998; 147: 387–90.
estrogen replacement therapy; risk; thromboembolism
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  K. Aschbacher, R. von Kanel, P. J. Mills, S. Hong, S. K. Roepke, B. T. Mausbach, T. L. Patterson, M. G. Ziegler, J. E. Dimsdale, S. Ancoli-Israel, et al. Combination of Caregiving Stress and Hormone Replacement Therapy is Associated With Prolonged Platelet Activation to Acute Stress Among Postmenopausal Women Psychosom Med, November 1, 2007; 69(9): 910 - 917. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. O. Skouby, J. J. Sidelmann, L. Nilas, and J. Jespersen A comparative study of the effect of continuous combined conjugated equine estrogen plus medroxyprogesterone acetate and tibolone on blood coagulability Hum. Reprod., April 1, 2007; 22(4): 1186 - 1191. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. M. Rexrode and J. E. Manson Are Some Types of Hormone Therapy Safer Than Others?: Lessons From the Estrogen and Thromboembolism Risk Study Circulation, February 20, 2007; 115(7): 820 - 822. [Full Text] [PDF]
|
|
|
|
|
|
M. Canonico, E. Oger, G. Plu-Bureau, J. Conard, G. Meyer, H. Levesque, N. Trillot, M.-T. Barrellier, D. Wahl, J. Emmerich, et al. Hormone Therapy and Venous Thromboembolism Among Postmenopausal Women: Impact of the Route of Estrogen Administration and Progestogens: The ESTHER Study Circulation, February 20, 2007; 115(7): 840 - 845. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. D. Curb, R. L. Prentice, P. F. Bray, R. D. Langer, L. Van Horn, V. M. Barnabei, M. J. Bloch, M. G. Cyr, M. Gass, L. Lepine, et al. Venous thrombosis and conjugated equine estrogen in women without a uterus. Arch Intern Med, April 10, 2006; 166(7): 772 - 780. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Jayachandran, K. Karnicki, R. S. Miller, W. G. Owen, K. S. Korach, and V. M. Miller Platelet Characteristics Change With Aging: Role of Estrogen Receptor {beta} J. Gerontol. A Biol. Sci. Med. Sci., June 1, 2005; 60(7): 815 - 819. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Jayachandran, R. Mukherjee, T. Steinkamp, P. LaBreche, M. P. Bracamonte, H. Okano, W. G. Owen, and V. M. Miller Differential effects of 17{beta}-estradiol, conjugated equine estrogen, and raloxifene on mRNA expression, aggregation, and secretion in platelets Am J Physiol Heart Circ Physiol, May 1, 2005; 288(5): H2355 - H2362. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Cushman, R. Prentice, B. M. Psaty, F. R. Rosendaal, and for the WHI Investigators Estrogen Plus Progestin and Risk of Venous Thrombosis--Reply JAMA, March 16, 2005; 293(11): 1322 - 1323. [Full Text] [PDF]
|
|
|
|
 |
|
 F. R. Rosendaal Venous Thrombosis: The Role of Genes, Environment, and Behavior Hematology, January 1, 2005; 2005(1): 1 - 12. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. P. V. Gomes and S. R. Deitcher Risk of Venous Thromboembolic Disease Associated With Hormonal Contraceptives and Hormone Replacement Therapy: A Clinical Review Arch Intern Med, October 11, 2004; 164(18): 1965 - 1976. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Cushman, L. H. Kuller, R. Prentice, R. J. Rodabough, B. M. Psaty, R. S. Stafford, S. Sidney, F. R. Rosendaal, and for the Women's Health Initiative Investigators Estrogen Plus Progestin and Risk of Venous Thrombosis JAMA, October 6, 2004; 292(13): 1573 - 1580. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Duggan, K. Marriott, R. Edwards, and J. Cuzick Inherited and Acquired Risk Factors for Venous Thromboembolic Disease Among Women Taking Tamoxifen to Prevent Breast Cancer J. Clin. Oncol., October 1, 2003; 21(19): 3588 - 3593. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Oger, M. Alhenc-Gelas, K. Lacut, M.-T. Blouch, N. Roudaut, V. Kerlan, M. Collet, J.-F. Abgrall, M. Aiach, P.-Y. Scarabin, et al. Differential Effects of Oral and Transdermal Estrogen/Progesterone Regimens on Sensitivity to Activated Protein C Among Postmenopausal Women: A Randomized Trial Arterioscler Thromb Vasc Biol, September 1, 2003; 23(9): 1671 - 1676. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. A. Anderson Jr. and F. A. Spencer Risk Factors for Venous Thromboembolism Circulation, June 17, 2003; 107(90231): I-9 - 16. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. D. Nelson, L. L. Humphrey, P. Nygren, S. M. Teutsch, and J. D. Allan Postmenopausal Hormone Replacement Therapy: Scientific Review JAMA, August 21, 2002; 288(7): 872 - 881. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Miller, B. K.S. Chan, and H. D. Nelson Postmenopausal Estrogen Replacement and Risk for Venous Thromboembolism: A Systematic Review and Meta-Analysis for the U.S. Preventive Services Task Force Ann Intern Med, May 7, 2002; 136(9): 680 - 690. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F.R. Rosendaal, F.M. Helmerhorst, and J.P. Vandenbroucke Female Hormones and Thrombosis Arterioscler Thromb Vasc Biol, February 1, 2002; 22(2): 201 - 210. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. H. Chen HRT and venous thromboembolism: more evidence of a link Can. Med. Assoc. J., January 1, 2001; 164(1): 87 - 87. [Full Text] [PDF]
|
|
|
|
 |
|
 D. Atkins and J. Miller Hormone replacement therapy was associated with increased venous thromboembolism and deep venous thrombosis Evid. Based Med., November 1, 2000; 5(6): 175 - 175. [Full Text]
|
|
|
|
|
|
D. Grady, N. K. Wenger, D. Herrington, S. Khan, C. Furberg, D. Hunninghake, E. Vittinghoff, S. Hulley, and for the Heart and Estrogen/progestin Replacement S Postmenopausal Hormone Therapy Increases Risk for Venous Thromboembolic Disease: The Heart and Estrogen/progestin Replacement Study Ann Intern Med, May 2, 2000; 132(9): 689 - 696. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Heit, M. D. Silverstein, D. N. Mohr, T. M. Petterson, W. M. O'Fallon, and L. J. Melton III Risk Factors for Deep Vein Thrombosis and Pulmonary Embolism: A Population-Based Case-Control Study Arch Intern Med, March 27, 2000; 160(6): 809 - 815. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Nishikawa, M. Ideishi, T. Nishimura, A. Kawamura, H. Kamochi, H. Tahara, Y. Tsuchiya, K. Shirai, M. Okabe, K. Arakawa, et al. Deep Venous Thrombosis and Pulmonary Thromboembolism Associated with a Huge Uterine Myoma: A Case Report Angiology, February 1, 2000; 51(2): 161 - 166. [Abstract] [PDF]
|
|
|
|
 |
|
 {blacktriangledown}Raloxifene to prevent postmenopausal osteoporosis DTB, May 1, 1999; 37(5): 33 - 36. [Abstract] [Full Text] [PDF]
|
|